Arginine

Arginine

Arginine

For Patients & Caregivers

Arginine has not been shown to prevent or treat cancer in humans.

Arginine is an amino acid that is produced by the body. It has been used for various conditions such as high blood pressure, heart conditions, migraine headaches and erectile dysfunction. Arginine has also been shown in clinical studies to enhance wound healing, immune function and athletic performance.
Arginine supplementation has been studied in cancer patients. Postoperative enteral formulas enhanced with arginine may improve wound healing, enhance immune status, and reduce length of hospital stay.

  • Angina
    Studies support the benefits of arginine for angina.
  • Atherosclerosis (Hardening of blood vessel walls)
    A few studies have shown that arginine may be effective for atherosclerosis.
  • Wound healing
    This use is supported by evidence from clinical trials.
  • Immune stimulation
    Arginine given in high doses may improve immune function cancer patients.
  • Erectile dysfunction
    Arginine has been shown in clinical trials to help improve sexual function in men.
  • Migraine headache
    When taken with ibuprofen, arginine increased pain relief in patients with migraine headaches.
  • Type 2 Diabetes
    Along with a low calorie diet and exercise, arginine may increase weight loss and improve insulin response in type 2 diabetic patients.
  • There is some evidence that suggests increase in breast tumor growth after taking arginine supplements but more studies are needed to establish this.
  • Long-term arginine supplementation in patients with peripheral artery disease may be harmful.
  • If you are taking medicine for high blood pressure, heart conditions, or erectile dysfunction (arginine may have additive blood pressure lowering effects.)
  • Abdominal pain
  • Bloating
  • Nausea
  • Diarrhea
  • Large doses of arginine can increase excretion of lysine in urine
Back to top

For Healthcare Professionals

2-amino-5-guanidinovaleric acid

Arginine is an amino acid that is synthesized in the body. Oral arginine has been used for various conditions such as hypertension, angina, atherosclerosis, migraine headache, and erectile dysfunction. Its vasodilatory properties are thought to be responsible for the beneficial effects. Arginine has also been used to enhance wound healing, immune function, and athletic performance.

Some studies support use of arginine in coronary artery and peripheral artery diseases (PADs) (10)(11)(12)(13); however, long term supplementation of arginine worsened PAD (14). Arginine along with antioxidant vitamins reduced the incidence of preeclampsia in high risk women (28). But arginine supplements did not improve blood pressure or kidney function in women with preeclampsia (15). Large doses of oral arginine improved subjective assessment of sexual function in men with organic erectile dysfunction (16). Arginine when combined with ibuprofen may increase pain relief in patients with migraine headaches (17). In addition, oral arginine has been studied for its effect on modifying or preventing the development of nitrate tolerance during continuous transdermal nitroglycerin therapy (18), and may enhance growth hormone release by inhibition of endogenous somatostatin (19). Arginine supplementation by enteral feeding was shown to decrease shock in severely burned patients (4).
Data from another trial suggest utility of arginine as an adjunctive therapy in patients with active tuberculosis (29).

Arginine supplementation has been studied in cancer patients. Postoperative enteral formulas enhanced with arginine may improve wound healing (1), enhance immune status (27), and reduce length of hospital stay (30).
Interestingly, arginine deprivation-based treatments are also being pursued as potential cancer treatments (31)(32).

Nuts, seeds, soy foods, legumes, and chocolate.

  • Fatigue
  • Hypertension
  • Angina
  • Atherosclerosis
  • Wound healing
  • Immune stimulation
  • Erectile dysfunction
  • Migraine headaches

Arginine is unique among amino acids for its vasodilatory properties (11). Arginine acts as a precursor for the synthesis of endogenous nitric oxide (NO) via the action of nitric oxide synthase (NOS). Nitric oxide’s functions as a paracrine-signaling molecule mediating vasodilation and inhibition of platelet activation, monocyte and leucocyte adhesion, and smooth muscle cell proliferation. Nitric oxide also helps to control vascular oxidative stress and redox-regulated gene expression (22). Arginine is also needed for the synthesis of creatine which is important in muscle contraction (22). In colorectal adenoma cells, arginine reduces the expression of survivin, an inhibitor of apoptosis, and induces iNOS expression (23).

Limited studies suggest that arginine supplementation may increase breast tumor growth, but more research is needed to examine this (9)(21).

  • Abdominal pain, bloating, nausea and diarrhea have been reported with oral administration (5)(8)(20).
  • Large doses of arginine can increase urinary excretion of lysine (21).
  • Due to arginine’s vasodilatory properties, theoretically it may have additive hypotensive effects with drugs such as antihypertensives, sildenafil and nitrates (11)(20).

High doses of intravenous arginine may results in the spillover into urine (22).


  1. Farreras N, Artigas V, Cardona D, Rius X, Trias M, Gonzalez JA. Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr. 2005;24(1):55-65.

  2. de Luis DA, Izaola O, Cuellar L, Terroba MC, Aller R. Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical head and neck cancer patients. Eur J Clin Nutr. 2004;58(11):1505-1508.

  3. Casas-Rodera P, Gomez-Candela C, Benitez S, et al. Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a prospective, randomized clinical trial. Nutr Hosp. Mar-Apr 2008;23(2):105-110.

  4. Yan H, Peng X, Huang Y, Zhao M, Li F, Wang P. Effects of early enteral arginine supplementation on resuscitation of severe burn patients. Burns. Mar 2007;33(2):179-184.

  5. Brittenden J, Park KG, Heys SD, et al. L-arginine stimulates host defenses in patients with breast cancer. Surgery. 1994;115(2):205-212.

  6. Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF. Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity. Kidney Int. 2003;63(2):522-533.

  7. Park KG, Heys SD, Blessing K, et al. Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) 1992;82(4):413-417.

  8. Gornik HL, Creager MA. Arginine and endothelial and vascular health. J Nutr. 2004;134(10 Suppl):2880S-2887S; discussion 2895S.

  9. Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP. L-arginine supplementation in peripheral arterial disease: no benefit and possible harm.Circulation. Jul 10 2007;116(2):188-195.

  10. Hladunewich MA, Derby GC, Lafayette RA, Blouch KL, Druzin ML, Myers BD. Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial. Obstet Gynecol. 2006;107(4):886-895.

  11. Sandrini G, Franchini S, Lanfranchi S, Granella F, Manzoni GC, Nappi G. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks. Int J Clin Pharmacol Res. 1998;18(3):145-150.

  12. Parker JO, Parker JD, Caldwell RW, Farrell B, Kaesemeyer WH. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy. J Am Coll Cardiol. 3 2002;39(7):1199-1203.

  13. Loche S, Carta D, Muntoni AC, Corda R, Pintor C. Oral administration of arginine enhances the growth hormone response to growth hormone releasing hormone in short children. Acta Paediatr. 1993;82(10):883-884.

  14. Cheng JW, Baldwin SN. L-arginine in the management of cardiovascular diseases. Ann Pharmacother. 2001;35(6):755-764.

  15. Wilmore D. Enteral and parenteral arginine supplementation to improve medical outcomes in hospitalized patients. J Nutr. 2004;134(10 Suppl):2863S-2867S; discussion 2895S.

  16. Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79-99.

  17. Paddon-Jones D, Borsheim E, Wolfe RR. Potential ergogenic effects of arginine and creatine supplementation. J Nutr. 2004;134(10 Suppl):2888S-2894S; discussion 2895S.

  18. Farazi A, Shafaat O, Sofian M, Kahbazi M. Arginine adjunctive therapy in active tuberculosis. Tuberc Res Treat. 2015;2015:205016.

  19. Feun LG, Kuo MT, Savaraj N. Arginine deprivation in cancer therapy. Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):78-82.

Back to top
Back to top
Email your questions and comments to aboutherbs@mskcc.org.

Last Updated